High-Sensitivity C-Reactive Protein (hs-CRP) What it measures: Systemic inflammation
Newer compounds like DHHB are also gaining attention in functional medicine for neuroprotection
y podran ir desde la disminucin del consumo de tabaco o una menor disposicin a buscar ayuda para dejar de fumar
When to Be Concerned While modest first month results are normal, certain situations warrant discussing with your provider: Severe nausea that prevents eating or drinking Vomiting that doesnt improve after the first week Signs of dehydration Severe abdominal pain No appetite changes at all by week four Most people tolerate Wegovy well, but your provider can help troubleshoot if issues arise
If you're exploring newer medications for weight management, you're not alone
It is FDA-indicated for three main uses: Cardiovascular Risk Reduction (In a Specific Group) To reduce the risk of major adverse cardiovascular events such as cardiovascular death, non-fatal heart attack, or non-fatal stroke in adults with established cardiovascular disease who also have obesity or are overweight